Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin M Warren

Showing results (181-190 of 236) with videos related to

Pageof 24
Sort By:
The Lancet. Microbe|February 22, 2026
Bedaquiline resistance in patients with Xpert MTB/RIF Ultra-tested rifampicin-resistant tuberculosis in the Western Cape, South Africa: a prospective studyJanré Steyn, Jennifer Williams, Fahd Naufal, et al.
Journal of Clinical Microbiology|August 21, 2015
Mycobacterium tuberculosis pncA Polymorphisms That Do Not Confer Pyrazinamide Resistance at a Breakpoint Concentration of 100 Micrograms per Milliliter in MGITMichael G Whitfield, Robin M Warren, Elizabeth M Streicher, et al.
Scientific Reports|November 13, 2019
Cytokine gene expression assay as a diagnostic tool for detection of Mycobacterium bovis infection in warthogs (Phacochoerus africanus)Eduard O Roos, Leeré A Scott, Sedzani Ndou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2017
Implications of Failure to Routinely Diagnose Resistance to Second-Line Drugs in Patients With Rifampicin-Resistant Tuberculosis on Xpert MTB/RIF: A Multisite Observational StudyKaren R Jacobson, Marinus Barnard, Mary B Kleinman, et al.
Frontiers in Microbiology|December 11, 2023
Advancing animal tuberculosis surveillance using culture-independent long-read whole-genome sequencingGiovanni Ghielmetti, Johannes Loubser, Tanya J Kerr, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 16, 2011
Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South AfricaElizabeth M Streicher, Borna Müller, Violet Chihota, et al.
Tuberculosis (Edinburgh, Scotland)|December 20, 2014
Genetic diversity of Mycobacterium tuberculosis isolated from tuberculosis patients in the Serengeti ecosystem in TanzaniaErasto V Mbugi, Bugwesa Z Katale, Keith K Siame, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 8, 2011
Mutations in the rrs A1401G gene and phenotypic resistance to amikacin and capreomycin in Mycobacterium tuberculosisFrederick A Sirgel, Marisa Tait, Robin M Warren, et al.
Plos One|September 24, 2013
Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South AfricaBorna Müller, Violet N Chihota, Manormoney Pillay, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2025
<i>In vitro</i> exposure to clofazimine can select for delamanid and pretomanid resistance in <i>Mycobacterium tuberculosis</i>Praharshinie Rupasinghe, Nabila Ismail, Wim Mulders, et al.
Pageof 24

Showing results (181-190 of 236) with videos related to

Sort By:
Pageof 24
The Lancet. Microbe|February 22, 2026
Bedaquiline resistance in patients with Xpert MTB/RIF Ultra-tested rifampicin-resistant tuberculosis in the Western Cape, South Africa: a prospective studyJanré Steyn, Jennifer Williams, Fahd Naufal, et al.
Journal of Clinical Microbiology|August 21, 2015
Mycobacterium tuberculosis pncA Polymorphisms That Do Not Confer Pyrazinamide Resistance at a Breakpoint Concentration of 100 Micrograms per Milliliter in MGITMichael G Whitfield, Robin M Warren, Elizabeth M Streicher, et al.
Scientific Reports|November 13, 2019
Cytokine gene expression assay as a diagnostic tool for detection of Mycobacterium bovis infection in warthogs (Phacochoerus africanus)Eduard O Roos, Leeré A Scott, Sedzani Ndou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2017
Implications of Failure to Routinely Diagnose Resistance to Second-Line Drugs in Patients With Rifampicin-Resistant Tuberculosis on Xpert MTB/RIF: A Multisite Observational StudyKaren R Jacobson, Marinus Barnard, Mary B Kleinman, et al.
Frontiers in Microbiology|December 11, 2023
Advancing animal tuberculosis surveillance using culture-independent long-read whole-genome sequencingGiovanni Ghielmetti, Johannes Loubser, Tanya J Kerr, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 16, 2011
Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South AfricaElizabeth M Streicher, Borna Müller, Violet Chihota, et al.
Tuberculosis (Edinburgh, Scotland)|December 20, 2014
Genetic diversity of Mycobacterium tuberculosis isolated from tuberculosis patients in the Serengeti ecosystem in TanzaniaErasto V Mbugi, Bugwesa Z Katale, Keith K Siame, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 8, 2011
Mutations in the rrs A1401G gene and phenotypic resistance to amikacin and capreomycin in Mycobacterium tuberculosisFrederick A Sirgel, Marisa Tait, Robin M Warren, et al.
Plos One|September 24, 2013
Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South AfricaBorna Müller, Violet N Chihota, Manormoney Pillay, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2025
<i>In vitro</i> exposure to clofazimine can select for delamanid and pretomanid resistance in <i>Mycobacterium tuberculosis</i>Praharshinie Rupasinghe, Nabila Ismail, Wim Mulders, et al.
Pageof 24